MAGRI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.092
EU - Europa 938
AS - Asia 223
AF - Africa 10
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.272
Nazione #
US - Stati Uniti d'America 1.077
IT - Italia 646
SE - Svezia 125
SG - Singapore 101
IN - India 48
DE - Germania 42
CN - Cina 35
RO - Romania 27
FI - Finlandia 23
ID - Indonesia 23
GB - Regno Unito 21
CA - Canada 15
BG - Bulgaria 9
IE - Irlanda 9
FR - Francia 8
TG - Togo 7
CH - Svizzera 5
HK - Hong Kong 5
AR - Argentina 4
PL - Polonia 4
BR - Brasile 3
IR - Iran 3
RS - Serbia 3
CZ - Repubblica Ceca 2
ES - Italia 2
IL - Israele 2
MK - Macedonia 2
NL - Olanda 2
PK - Pakistan 2
RU - Federazione Russa 2
TW - Taiwan 2
UA - Ucraina 2
AL - Albania 1
AU - Australia 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
JP - Giappone 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
PT - Portogallo 1
SC - Seychelles 1
Totale 2.272
Città #
Rome 341
Fairfield 161
Chandler 109
Ashburn 91
Woodbridge 73
Seattle 70
Singapore 68
Houston 65
Cambridge 58
Wilmington 43
Santa Clara 36
Dearborn 28
Princeton 27
Milan 23
Jakarta 22
San Paolo di Civitate 22
Timisoara 22
Lawrence 20
Ann Arbor 19
San Diego 17
Beijing 16
Helsinki 16
New York 15
Millbury 13
Plano 11
Boston 10
Bremen 9
Dublin 9
Sofia 9
Cassano Allo Ionio 8
Toronto 8
Andover 7
Ariccia 7
Boardman 7
Lomé 7
Stockholm 7
Bernareggio 6
Fremont 6
Frosinone 6
Norwalk 6
Arezzo 5
Catania 5
Grafing 5
Latina 5
Los Angeles 5
Ottawa 5
Palermo 5
Argenta 4
Bologna 4
Cagliari 4
Canterbury 4
Federal 4
Montesilvano Marina 4
Parma 4
Sacramento 4
Warsaw 4
Caserta 3
Dallas 3
Falls Church 3
Frankfurt am Main 3
Genoa 3
Glasgow 3
Hong Kong 3
Lappeenranta 3
Phoenix 3
Bühl 2
Castegnero 2
Centrale 2
Chatou 2
Florence 2
Lahore 2
Levallois-perret 2
London 2
Malmesbury 2
Monterotondo 2
New Taipei City 2
Pescorocchiano 2
Pieve Emanuele 2
Pisa 2
Prilep 2
Ravenna 2
Redwood City 2
San Cesareo 2
Santa Maria Capua Vetere 2
Scilla 2
Selevac 2
Shenyang 2
Slough 2
Sorrento 2
Southend 2
St. Gallen 2
Taganrog 2
Torino 2
Trevi 2
Trieste 2
Wuhan 2
Zhengzhou 2
Al `Amiriyah 1
Almaty 1
Americana 1
Totale 1.663
Nome #
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 147
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: a real-world experience 120
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer 117
Automated classification of focal breast lesions according to S-detect: validation and role as a clinical and teaching tool 109
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 107
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 99
Circulating tumor cells in right-and left-sided colorectal cancer 93
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 91
Pregnancy-associated breast cancer: a diagnostic and therapeutic challenge 90
EpCAM expressing circulating tumor cells in colorectal cancer 88
Prognostic role of circulating tumor cell trajectories in metastatic colorectal cancer 86
Prolactin as a potential negative predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO) 86
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors 85
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria? 81
Eribulin in male patients with breast cancer: The first report of clinical outcomes 81
Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules 81
Eribulin in brain metastases of breast cancer. outcomes of the EBRAIM prospective observational trial 80
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer 72
RAS mutation conversion in bevacizumab-treated metastatic colorectal cancer patients: a liquid biopsy based study 72
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile 70
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients. A multicenter Italian experience 68
Correlation of body composition by computerized tomography and metabolic parameters with survival of nivolumab-treated lung cancer patients 63
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 63
Role of chemotherapy in vulvar cancers: time to rethink standard of care? 56
null 49
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in ER+/HERr2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 45
The promise of liquid biopsy in cancer: a clinical perspective 43
T-DM1 Efficacy in patients with HER2-positive metastatic breast cancer progressing after a Taxane Plus Pertuzumab and Trastuzumab. An italian multicenter observational study 43
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence 36
Oncotype DX predictive nomogram for recurrence score output: the novel system ADAPTED01 based on quantitative immunochemistry analysis 33
Precision medicine in breast cancer: do MRI biomarkers identify patients who truly benefit from the Oncotype DX Recurrence Score® Test? 32
Sequential isolation and characterization of single CTCs and large CTC clusters in metastatic colorectal cancer patients 28
Is cancer an intelligent species? 26
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer 17
Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab 15
Blood Extracellular Vesicles beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients 6
Totale 2.478
Categoria #
all - tutte 7.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020356 0 0 0 0 37 57 55 56 45 51 28 27
2020/2021223 25 17 14 8 21 23 1 6 22 57 13 16
2021/2022335 37 18 21 10 39 16 10 18 33 9 79 45
2022/2023520 74 90 47 39 68 43 17 30 45 24 27 16
2023/2024444 22 44 26 35 40 55 21 44 8 50 55 44
2024/2025374 32 75 73 81 113 0 0 0 0 0 0 0
Totale 2.478